Efor news
31/07/2025
Efor completes third acquisition of the year with the integration of PES
Efor continues its targeted growth strategy with the acquisition of Process Engineering Specialists (PES), a well-established play
24/07/2025
ECHA accelerates the transition towards animal-free chemical evaluations
The ECHA is announcing its commitment to drastically reduce, and then eliminate, animal testing.
10/07/2025
Women in Engineering Day: Amandine’s story of leadership, resilience and technical excellence
Amandine Pousse shares her inspiring engineering journey on International Women in Engineering Day.
3/07/2025
Unlocking the Potential of Comparative Genomics in Bacterial Research
This article explores the key steps and methodologies in bacterial comparative genomics.
26/06/2025
Efor takes action for cancer research with the “Get Your Sneakers On” challenge
Our employees took part in the “Get Your Sneakers On” challenge organized by the Centre Léon Bérard.
Join our team
Consult our offers
24/06/2025
Efor strengthens its European presence with a new office in Frankfurt
Efor continues its international expansion with the opening of its first office in Frankfurt, Germany.
19/06/2025
Bioproduction 2030: Innovate, train, collaborate to build the future of biopharmaceuticals
Efor at the National Day of Bioproduction of Biopharmaceuticals.
12/06/2025
Lifetime and Lifecycle in the Upcoming ISO 10993-1 Standard (2025): Who, When, What, and How?
Analysis of the life cycle and service life of a medical device to better anticipate the challenges of biological evaluation under
5/06/2025
Designing a PMCF Study: The Question of Sample Size with a Fictional Example
PMCF studies are key tools for meeting MDR requirements and ensuring device safety and performance.
28/05/2025
Efor Metz: a new workspace to support our growth
Efor Metz team has officially moved into their new office located at 1 rue Antoine Chaptal.
22/05/2025
The Impact of Presidential Executive Orders on the Pharmaceutical and Medical Devices sectors in the USA
Recent developments in United States (US) healthcare regulation have brought significant changes to the process of approving pharm
7/05/2025
Heading to North America
2025: A milestone in our international growthBringing together PharmEng Technology, Project Delivery Partners, and EFOR in 2025 ma
